Generics - China

Filter

Current filters:

China

Popular Filters

Chinese heparin API market to account for about 80% of global demand; report

Chinese heparin API market to account for about 80% of global demand; report

21-10-2014

It is projected that the heparin active pharmaceutical ingredient (API) in China will achieve an additional…

Cardio-vascularChinaGenericsMarkets & Marketing

Amerigen Pharma and Ningbo Menovo link up on generics for US market

27-08-2014

US generic drugmaker Amerigen Pharmaceuticals and China’s Ningbo Menovo Pharmaceutical have entered…

Amerigen PharmaceuticalsChinaGenericsNingbo MenovoProductionResearchUSA

Medicines Patent Pool broadens collaboration with Gilead Sciences

24-07-2014

The Medicines Patent Pool (MPP) has entered into a new licensing agreement with US biotech firm Gilead…

Anti-viralsChinaGenericsGilead SciencesIndiaLicensingProductiontenofovir alafenamide

Actavis to shed another business, its Actavis Foshan unit in China

Actavis to shed another business, its Actavis Foshan unit in China

26-01-2014

US generics major Actavis revealed a second divestiture this month, saying it has signed and completed…

ActavisAsia-PacificChinaGenericsMergers & AcquisitionsZhejiang Chiral

Lack of familiarity with biosimilars among South Korean oncologists

Lack of familiarity with biosimilars among South Korean oncologists

16-12-2013

South Korean oncologists are significantly less familiar with biosimilars than oncologists surveyed in…

Asia-PacificBiosimilarsChinaGenericsOncology

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

Russia, Ukraine and the Baltic states increasing in importance on the contract manufacturing market

11-12-2013

Russia seems to be an attractive country for pharmaceutical contract manufacturing, chiefly because of…

Asia-PacificChinaEastern EuropeGenericsIndiaProductionRegulationRussiaUkraine

Back to top